Centre asks Serum Institute, Bharat Biotech to lower prices of Covishield, Covaxin: Sources
The central government has asked the Serum Institute of India and Bharat Biotech to lower the price of COVID vaccines, Covishield and Covaxin as India gears up to vaccinate all aged above 18 from May 1, official sources said on Monday.
READ MORE:
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
